Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles

New drugs targeting bile acid metabolism are currently being evaluated in clinical studies for their potential to treat cholestatic liver diseases, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Changes in bile acid metabolism, however, translate into an alterati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Boyan, Kuipers, Folkert, de Boer, Jan Freark, Kuivenhoven, Jan Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745251/
https://www.ncbi.nlm.nih.gov/pubmed/35011746
http://dx.doi.org/10.3390/jcm11010004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745251/
https://www.ncbi.nlm.nih.gov/pubmed/35011746
http://dx.doi.org/10.3390/jcm11010004

Ejemplares similares